Question · Q3 2025
Pete Lucas asked for more details on the competitive landscape within the Alzheimer's imaging market, particularly for tau tangle imaging, and how MK-6240 is positioned against other products.
Answer
CEO Brian Markison described MK-6240 as a second-generation tau agent with demonstrated superiority in studies compared to commercially available options like Talvet. He emphasized the increasing importance of tau imaging for staging and longitudinal management of Alzheimer's disease.